FDA allows Houston cancer doctor to resume drug trial
Por um escritor misterioso
Descrição
Federal regulators have lifted a partial hold on a clinical trial performed by Stanislaw
Celebrating its 30th anniversary, BMT at UMMC is nationally recognized - University of Mississippi Medical Center
Sen. Sanders pushes NIH to rein in drug prices
Here's who could be helped by new cancer drug — and when
In the compelling follow-up to the internationally award-winning documentary, Burzynski, the Movie; Burzynski: Cancer is Serious Business, Part II
Burzynski: Cancer Is Serious Business Part II
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study - The Lancet Oncology
Hagop M. Kantarjian MD Anderson Cancer Center
Texas Medical Board sanctions controversial cancer doctor Burzynski
Dr. Scott Olsson Houston Methodist
James P. Allison, Ph.D., Immunotherapy Researcher
World's First Gene Therapy Clinical Trial for Glycogen Storage Disease Approved by FDA - Connecticut Children's
New Survey Reveals Cancer Survivors' Attitudes to Care, Unmet Needs, Article
Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma
Harnessing the Immune System to Fight Cancer - The New York Times
de
por adulto (o preço varia de acordo com o tamanho do grupo)
